APOBEC3G & HTLV-I: Inhibition without deamination

28Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

APOBEC3G is a cellular cytidine deaminase that was recently identified as the Vif-sensitive antiviral host factor responsible for the restriction of vif-defective HIV-1 in primary human cells and certain non-permissive T cell lines. Inhibition of HIV-1 replication is thought to be the result of APOBEC3G-induced hypermutation of the viral genome that occurs early during reverse transcription. Against this backdrop is a new report from the Uchiyama laboratory that proposes deaminase-independent restriction of HTLV-1 by APOBEC3G (Sasada et al. Retrovirology 2005, 2:32). These findings combined with recent reports of deaminase-independent inhibition of Hepatitis B virus as well as HIV-1 suggest that cytidine deaminase activity and antiviral activity may be separable functional properties of APOBEC3G. © 2005 Strebel; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Strebel, K. (2005, May 29). APOBEC3G & HTLV-I: Inhibition without deamination. Retrovirology. https://doi.org/10.1186/1742-4690-2-37

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free